NCT04398745: A Study of Belantamab Mafodotin Monotherapy in Multiple Myeloma Participants With Normal and Varying Degree of Impaired Renal Function
- State
- Under way
- Phase
- Phase 1
- People
- 36 taking part
- Started
- 9 Oct 2020
- Primary completion
- 21 Apr 2025
- Arms
- Part 1: Participants with normal/mild impaired renal function, Part 1: Participants with severe renal impairment, Part 2: Participants with ESRD (not on dialysis), Part 2: Participants with ESRD (on hemodialysis)
- Results
- Posted on the registry
- 21 May 2020: Trial registered
- 9 Oct 2020: Trial started
- 1 Jul 2026: Trial results posted